Developer docs
API playgroundTry for free, no card

Search company profiles

Pharmachem Laboratories

Full company profile

uuid000jfvl

Namestring
Pharmachem Laboratories
Legal namestring
Pharmachem Innovations, LLC
Company typeenum
Private
Founded yearint
1972
Descriptiontext

Pharmachem Innovations, LLC (formerly Pharmachem Laboratories) is a Kearny, New Jersey-based B2B nutraceuticals company that develops, manufactures, and distributes proprietary branded ingredients, specialty delivery systems, and contract-manufactured finished products for nutritional product companies and supplement brands globally. The company was originally founded in 1972, operated under the Pharmachem name until 2017, was carved out of Ashland Inc. (NYSE: ASH) by Turnspire Capital Partners in August 2024, and relaunched as Pharmachem Innovations, LLC in September 2024 under Executive Chairman Maurice Murphy and Interim CEO Jeff Rogers. The business operates from three manufacturing facilities in New Jersey, Utah (United States), and Tamaulipas (Mexico), serving both emerging DTC brands and established supplement companies.

The company's proprietary technology portfolio centers on trademarked branded ingredients — Phase 2 Carb Controller (white kidney bean extract), Cran-Max cranberry concentrate, GPM Fermented Nutrients, Prenulin (L-arabinose plus chromium picolinate), and Perluxan hops extract — each backed by a clinical study dossier (14, 6, 3, and 5 studies respectively) that supports FDA-eligible structure-function claims for customers. Alongside these, Pharmachem offers delivery-system platforms (StableFizz effervescent granulation, Nutrapress BND and CHW tablet binders) and the Acti-Solve particle engineering platform that modifies ingredient solubility, dispersibility, and flavor. Manufacturing capabilities include spray-drying, micronizing, fluid bed and wet granulation, microencapsulation, and blending, with finished-goods formats spanning stick-packs, canisters, pre-blends, and drum-to-hopper blends.

Revenue is generated through four streams: sale of proprietary branded ingredients (license-style), custom formulation services (concept-to-launch), contract manufacturing (toll and turnkey), and authorized distribution of third-party specialty ingredients (Probiotical probiotics, Waitaki Biosciences natural ingredients, NordicCherry tart cherry extract). Pricing is quote-based and undisclosed, the GTM motion is sales-led direct-to-manufacturer, and the customer base spans hydration, sports nutrition, women's health, weight management, and joint health supplement categories. The business currently employs 251-500 people.

Short descriptiontext

Pharmachem Innovations is a B2B nutraceuticals company that develops, manufactures, and distributes proprietary branded ingredients, particle engineering platforms, and contract manufacturing services for nutritional product companies and supplement brands globally.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersKearny, United States
HQ citystring
Kearny
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nutraceutical ingredients, dietary supplements manufacturing, contract manufacturing services, custom formulation, branded ingredient supplier
Industry2 codes
1Probiotics & Digestive Health Supplements
CodeCRADAGAFPrimaryYes
2Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives
CodeEUAAAIAKPrimaryNo
NAICS code2 codes
  • Pharmaceutical and Medicine Manufacturing3254
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Nutraceutical Ingredients and Contract Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Proprietary Branded Ingredients
TypeOne Time License
Description

Sale of proprietary branded nutraceutical ingredients including Phase 2 Carb Controller, GPM Fermented Nutrients, Cran-Max, Prenulin, Perluxan, and delivery systems. Revenue from both direct ingredient sales to manufacturers and inclusion in custom formulations.

pharmachem.com
2Custom Formulation Services
TypeProfessional Services
Description

Bespoke formulation services for nutritional product companies, from concept to final execution and launch. Collaborative business approach understanding customer objectives and requirements for new product development.

pharmachem.com
3Contract Manufacturing Services
TypeProfessional Services
Description

Toll manufacturing and full turnkey manufacturing services including spray-drying, micronizing, fluid bed and wet granulation, microencapsulation, and blending. Products delivered in stick-pack, canister, pre-blend, or drum-to-hopper blend formats.

pharmachem.com
4Distributed Specialty Ingredients
TypeOne Time License
Description

Distribution of third-party specialty ingredients including Probiotical Probiotics, Waitaki Biosciences Natural Ingredients, and NordicCherry Tart Cherry Extract as authorized distributors.

pharmachem.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 8 records shown
1Phase 2™ Carb Controller
Description

A natural extract of white kidney bean that reduces carbohydrate absorption, backed by 14 human clinical studies and 2 allowable structure function claims.

pharmachem.com
+7 more records
Core offering1 text field

Pharmachem Innovations is a B2B provider of proprietary branded nutraceutical ingredients, custom formulation services, and contract manufacturing for nutritional product companies. The company manufactures and supplies clinically-studied ingredients including Phase 2 Carb Controller, Cran-Max, GPM Fermented Nutrients, Prenulin, and Perluxan, along with proprietary delivery systems (Acti-Solve, StableFizz, Nutrapress), enabling customers to develop finished dietary supplements, functional beverages, and sports nutrition products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 14 human clinical studies supporting Phase 2 Carb Controller efficacy
+2 more records
Product overview1 text field

Pharmachem Innovations is a provider of nutraceuticals products and solutions with a portfolio of proprietary branded ingredients, delivery systems, and performance ingredients. The core offerings include branded weight management and health ingredients (Phase 2™, Cran-Max™, GPM™, Prenulin™, Perluxan™), proprietary delivery systems (StableFizz™, Nutrapress™ BND/CHW), and distributed specialty ingredients (Probiotical®, Waitaki Biosciences®, NordicCherry®). The company also provides technology platforms (Acti-Solve™ particle engineering) and services including custom formulation and contract manufacturing. The products work together to enable customers to develop and produce nutritional supplements with enhanced bioavailability, improved taste, and various health benefits.

Product and service11 records
1Phase 2 Carb Controller
CategoryBranded Ingredient
Description

A natural extract of white kidney bean that reduces carbohydrate absorption, backed by 14 human clinical studies and 2 allowable structure/function claims. Sold as a proprietary branded ingredient to nutritional product manufacturers.

2Cran-Max Cranberry Concentrate
CategoryBranded Ingredient
Description

Cranberry concentrate made from North American cranberries to support urinary tract health, supported by 6 clinical studies meeting US-FDA structure/function claims.

3GPM Fermented Nutrients
CategoryBranded Ingredient
Description

Whole food bound fermented nutrients with improved bioavailability and/or blood concentration levels versus conventional vitamins and minerals, made via proprietary fermentation process and backed by 3 human clinical studies.

4Prenulin Blend
CategoryBranded Ingredient
Description

Proprietary blend of L-arabinose and Chromax chromium picolinate designed to support blood glucose management, with clinical studies available.

5Perluxan Hops Extract
CategoryBranded Ingredient
Description

Extract of hops cones produced via super critical CO2 with standardized alpha acids to support joint health, backed by 5 clinical studies.

6Acti-Solve Engineered Solutions
CategoryTechnology Platform
Description

Proprietary particle engineering solutions that mask off flavors, reduce unpleasant odors, and improve poor solubility of troublesome ingredients for beverage and other applications, modifying ingredients for better dispersibility and improved flavor profile.

7Nutrapress BND
CategoryDelivery System
Description

Proprietary organic ingredient that delivers good binding and flowability for swallow-only tablets.

8Nutrapress CHW
CategoryDelivery System
Description

Proprietary organic ingredient that delivers good binding and flowability for chewable tablets.

9StableFizz Effervescent Granulation
CategoryDelivery System
Description

Complete system for creating fizzy drinks that combines acid and base components in a proprietary process to prevent premature reaction.

10Contract Manufacturing Services
CategoryManufacturing Service
Description

Toll manufacturing and full turnkey contract manufacturing for powder supplements including spray-drying, micronizing, fluid bed and wet granulation, microencapsulation, and blending. Products delivered in stick-pack, canister, pre-blend, or drum-to-hopper blend formats.

11Custom Formulation Services
CategoryFormulation Service
Description

Full-service custom formulation from concept to final execution and launch, including formula design, ingredient sourcing, and finished product manufacturing for nutritional product companies.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialty ingredients manufacturer serving human nutrition, animal nutrition, and pharma with branded encapsulated and functional ingredients; comparable to Pharmachem as a B2B ingredients platform with proprietary technologies and clinical backing.

TypeDirect peer
Description

Manufacturer and supplier of branded, clinically-supported nutraceutical ingredients (Curcumin C3 Complex, BioPerine, etc.); highly comparable to Pharmachem's Phase 2/Cran-Max/Perluxan branded portfolio and ingredient-licensing model.

3Gencor
TypeDirect peer
Description

Branded specialty ingredients supplier focused on men's health, weight management, and sports nutrition with proprietary branded ingredients backed by clinical studies; directly comparable to Pharmachem's branded portfolio go-to-market.

TypeDirect peer
Description

Ingredient solutions company marketing science-backed branded ingredients to dietary supplement and functional food brands; peer due to overlapping branded ingredient portfolio, clinical substantiation approach, and B2B sales motion.

TypeBroad incumbent
Description

Global nutrition solutions provider offering custom premixes, branded ingredients, and contract manufacturing; broader-scale peer that competes with Pharmachem in formulation, premix, and ingredient supply to supplement brands.

TypeBroad incumbent
Description

Global taste and nutrition company with a substantial health and wellness ingredients portfolio; large incumbent competing with Pharmachem across functional ingredients and customized nutrition solutions.

TypeBroad incumbent
Description

Global CDMO with nutraceutical and consumer health manufacturing services; comparable as a contract manufacturer serving nutrition customers, with the new Interim CEO having previously held leadership at Lonza.

TypeDirect peer
Description

Supplier of natural and botanical-based ingredients for nutrition and dietary supplements; comparable to Pharmachem's Cran-Max and other plant-derived branded ingredients in a similar B2B ingredients model.

TypeBroad incumbent
Description

Specialty ingredient producer serving health, nutrition, and personal care markets with mineral- and botanical-based ingredients; comparable as a B2B ingredient manufacturer serving supplement and nutrition customers.

TypeEmerging player
Description

New Zealand-based natural ingredients supplier currently distributed by Pharmachem; comparable as a botanical/natural ingredients player with overlapping end-market exposure in bone, joint, and cognitive health.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharmachem Laboratories

Nutraceutical Ingredients and Contract Manufacturingpharmachemlabs.com

Pharmachem Innovations is a B2B nutraceuticals company that develops, manufactures, and distributes proprietary branded ingredients, particle engineering platforms, and contract manufacturing services for nutritional product companies and supplement brands globally.

What Pharmachem Laboratories does

Pharmachem Innovations, LLC (formerly Pharmachem Laboratories) is a Kearny, New Jersey-based B2B nutraceuticals company that develops, manufactures, and distributes proprietary branded ingredients, specialty delivery systems, and contract-manufactured finished products for nutritional product companies and supplement brands globally. The company was originally founded in 1972, operated under the Pharmachem name until 2017, was carved out of Ashland Inc. (NYSE: ASH) by Turnspire Capital Partners in August 2024, and relaunched as Pharmachem Innovations, LLC in September 2024 under Executive Chairman Maurice Murphy and Interim CEO Jeff Rogers. The business operates from three manufacturing facilities in New Jersey, Utah (United States), and Tamaulipas (Mexico), serving both emerging DTC brands and established supplement companies.

The company's proprietary technology portfolio centers on trademarked branded ingredients — Phase 2 Carb Controller (white kidney bean extract), Cran-Max cranberry concentrate, GPM Fermented Nutrients, Prenulin (L-arabinose plus chromium picolinate), and Perluxan hops extract — each backed by a clinical study dossier (14, 6, 3, and 5 studies respectively) that supports FDA-eligible structure-function claims for customers. Alongside these, Pharmachem offers delivery-system platforms (StableFizz effervescent granulation, Nutrapress BND and CHW tablet binders) and the Acti-Solve particle engineering platform that modifies ingredient solubility, dispersibility, and flavor. Manufacturing capabilities include spray-drying, micronizing, fluid bed and wet granulation, microencapsulation, and blending, with finished-goods formats spanning stick-packs, canisters, pre-blends, and drum-to-hopper blends.

Revenue is generated through four streams: sale of proprietary branded ingredients (license-style), custom formulation services (concept-to-launch), contract manufacturing (toll and turnkey), and authorized distribution of third-party specialty ingredients (Probiotical probiotics, Waitaki Biosciences natural ingredients, NordicCherry tart cherry extract). Pricing is quote-based and undisclosed, the GTM motion is sales-led direct-to-manufacturer, and the customer base spans hydration, sports nutrition, women's health, weight management, and joint health supplement categories. The business currently employs 251-500 people.

Pharmachem Laboratories firmographics

Firmographics
Name
Pharmachem Laboratories
Legal name
Pharmachem Innovations, LLC
Website
https://pharmachemlabs.com
Company type
Private
Founded year
1972
Operating status
Operating
Headcount range
251–500 employees
Short description
Pharmachem Innovations is a B2B nutraceuticals company that develops, manufactures, and distributes proprietary branded ingredients, particle engineering platforms, and contract manufacturing services for nutritional product companies and supplement brands globally.
Ownership category
akta.pro rank

Pharmachem Laboratories industry classification

Industry
Product category
Nutraceutical Ingredients and Contract Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
SIC
Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry
Probiotics & Digestive Health Supplements (CRADAGAF)
akta.pro secondary industry
Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

Keywords

  • Nutraceutical ingredients
  • Dietary supplements manufacturing
  • Contract manufacturing services
  • Custom formulation
  • Branded ingredient supplier

Where Pharmachem Laboratories is headquartered

Location

Headquarters

HQ city
Kearny
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Pharmachem Laboratories business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Proprietary Branded Ingredients: Sale of proprietary branded nutraceutical ingredients including Phase 2 Carb Controller, GPM Fermented Nutrients, Cran-Max, Prenulin, Perluxan, and delivery systems. Revenue from both direct ingredient sales to manufacturers and inclusion in custom formulations.
  2. Custom Formulation Services: Bespoke formulation services for nutritional product companies, from concept to final execution and launch. Collaborative business approach understanding customer objectives and requirements for new product development.
  3. Contract Manufacturing Services: Toll manufacturing and full turnkey manufacturing services including spray-drying, micronizing, fluid bed and wet granulation, microencapsulation, and blending. Products delivered in stick-pack, canister, pre-blend, or drum-to-hopper blend formats.
  4. Distributed Specialty Ingredients: Distribution of third-party specialty ingredients including Probiotical Probiotics, Waitaki Biosciences Natural Ingredients, and NordicCherry Tart Cherry Extract as authorized distributors.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Pharmachem Laboratories product offering

Product offering

Core offering

Pharmachem Innovations is a B2B provider of proprietary branded nutraceutical ingredients, custom formulation services, and contract manufacturing for nutritional product companies. The company manufactures and supplies clinically-studied ingredients including Phase 2 Carb Controller, Cran-Max, GPM Fermented Nutrients, Prenulin, and Perluxan, along with proprietary delivery systems (Acti-Solve, StableFizz, Nutrapress), enabling customers to develop finished dietary supplements, functional beverages, and sports nutrition products.

Product overview

Pharmachem Innovations is a provider of nutraceuticals products and solutions with a portfolio of proprietary branded ingredients, delivery systems, and performance ingredients. The core offerings include branded weight management and health ingredients (Phase 2™, Cran-Max™, GPM™, Prenulin™, Perluxan™), proprietary delivery systems (StableFizz™, Nutrapress™ BND/CHW), and distributed specialty ingredients (Probiotical®, Waitaki Biosciences®, NordicCherry®). The company also provides technology platforms (Acti-Solve™ particle engineering) and services including custom formulation and contract manufacturing. The products work together to enable customers to develop and produce nutritional supplements with enhanced bioavailability, improved taste, and various health benefits.

Differentiator

Problem solved

Functional benefit

Brands

  • Phase 2™ Carb Controller: A natural extract of white kidney bean that reduces carbohydrate absorption, backed by 14 human clinical studies and 2 allowable structure function claims.
  • Cran-Max™ Cranberry Concentrate
  • GPM™ Fermented Nutrients
  • Prenulin™ Blend
  • Perluxan™ Hops Extract
  • Acti-Solve™
  • StableFizz™
  • Nutrapress™ BND and CHW

Products and services

  • Phase 2 Carb Controller A natural extract of white kidney bean that reduces carbohydrate absorption, backed by 14 human clinical studies and 2 allowable structure/function claims. Sold as a proprietary branded ingredient to nutritional product manufacturers.
  • Cran-Max Cranberry Concentrate Cranberry concentrate made from North American cranberries to support urinary tract health, supported by 6 clinical studies meeting US-FDA structure/function claims.
  • GPM Fermented Nutrients Whole food bound fermented nutrients with improved bioavailability and/or blood concentration levels versus conventional vitamins and minerals, made via proprietary fermentation process and backed by 3 human clinical studies.
  • Prenulin Blend Proprietary blend of L-arabinose and Chromax chromium picolinate designed to support blood glucose management, with clinical studies available.
  • Perluxan Hops Extract Extract of hops cones produced via super critical CO2 with standardized alpha acids to support joint health, backed by 5 clinical studies.
  • Acti-Solve Engineered Solutions Proprietary particle engineering solutions that mask off flavors, reduce unpleasant odors, and improve poor solubility of troublesome ingredients for beverage and other applications, modifying ingredients for better dispersibility and improved flavor profile.
  • Nutrapress BND Proprietary organic ingredient that delivers good binding and flowability for swallow-only tablets.
  • Nutrapress CHW Proprietary organic ingredient that delivers good binding and flowability for chewable tablets.
  • StableFizz Effervescent Granulation Complete system for creating fizzy drinks that combines acid and base components in a proprietary process to prevent premature reaction.
  • Contract Manufacturing Services Toll manufacturing and full turnkey contract manufacturing for powder supplements including spray-drying, micronizing, fluid bed and wet granulation, microencapsulation, and blending. Products delivered in stick-pack, canister, pre-blend, or drum-to-hopper blend formats.
  • Custom Formulation Services Full-service custom formulation from concept to final execution and launch, including formula design, ingredient sourcing, and finished product manufacturing for nutritional product companies.

Quantifiable outcome

  • 14 human clinical studies supporting Phase 2 Carb Controller efficacy
  • +2 more outcomes

Companies that use Pharmachem Laboratories

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Pharmachem Laboratories technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Pharmachem Laboratories partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Pharmachem Laboratories competitors and assessment

Company assessment

Direct peers

  • Balchem Corporation: Specialty ingredients manufacturer serving human nutrition, animal nutrition, and pharma with branded encapsulated and functional ingredients; comparable to Pharmachem as a B2B ingredients platform with proprietary technologies and clinical backing.
  • Sabinsa Corporation: Manufacturer and supplier of branded, clinically-supported nutraceutical ingredients (Curcumin C3 Complex, BioPerine, etc.); highly comparable to Pharmachem's Phase 2/Cran-Max/Perluxan branded portfolio and ingredient-licensing model.
  • Gencor: Branded specialty ingredients supplier focused on men's health, weight management, and sports nutrition with proprietary branded ingredients backed by clinical studies; directly comparable to Pharmachem's branded portfolio go-to-market.
  • PLT Health Solutions: Ingredient solutions company marketing science-backed branded ingredients to dietary supplement and functional food brands; peer due to overlapping branded ingredient portfolio, clinical substantiation approach, and B2B sales motion.
  • Nexira: Supplier of natural and botanical-based ingredients for nutrition and dietary supplements; comparable to Pharmachem's Cran-Max and other plant-derived branded ingredients in a similar B2B ingredients model.

Broad incumbents

  • Glanbia Nutritionals: Global nutrition solutions provider offering custom premixes, branded ingredients, and contract manufacturing; broader-scale peer that competes with Pharmachem in formulation, premix, and ingredient supply to supplement brands.
  • Kerry Group: Global taste and nutrition company with a substantial health and wellness ingredients portfolio; large incumbent competing with Pharmachem across functional ingredients and customized nutrition solutions.
  • Lonza Group: Global CDMO with nutraceutical and consumer health manufacturing services; comparable as a contract manufacturer serving nutrition customers, with the new Interim CEO having previously held leadership at Lonza.
  • Innophos Holdings: Specialty ingredient producer serving health, nutrition, and personal care markets with mineral- and botanical-based ingredients; comparable as a B2B ingredient manufacturer serving supplement and nutrition customers.

Emerging players

  • Waitaki Biosciences: New Zealand-based natural ingredients supplier currently distributed by Pharmachem; comparable as a botanical/natural ingredients player with overlapping end-market exposure in bone, joint, and cognitive health.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Pharmachem Laboratories social profiles

Digital presence

Pharmachem Laboratories financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharmachem Laboratories leadership team

Management profile

Number of profiles

Profiles2 records

Pharmachem Laboratories funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharmachem Laboratories M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmachem Laboratories

What does Pharmachem Laboratories do?

Pharmachem Innovations is a B2B provider of proprietary branded nutraceutical ingredients, custom formulation services, and contract manufacturing for nutritional product companies. The company manufactures and supplies clinically-studied ingredients including Phase 2 Carb Controller, Cran-Max, GPM Fermented Nutrients, Prenulin, and Perluxan, along with proprietary delivery systems (Acti-Solve, StableFizz, Nutrapress), enabling customers to develop finished dietary supplements, functional beverages, and sports nutrition products.

Is Pharmachem Laboratories a public or private company?

Pharmachem Laboratories is a private company. It is classified as private equity controlled and is currently operating.

When was Pharmachem Laboratories founded?

Pharmachem Laboratories was founded in 1972. It employs 251 to 500 people.

Where is Pharmachem Laboratories based?

Pharmachem Laboratories is headquartered in Kearny, United States, in the North America region.

How does Pharmachem Laboratories make money?

Four revenue lines are on record. Proprietary Branded Ingredients are the primary driver. The others are custom Formulation Services, contract Manufacturing Services and distributed Specialty Ingredients.

Who are Pharmachem Laboratories's main competitors?

Direct peers on record are Balchem Corporation, Sabinsa Corporation, Gencor, PLT Health Solutions and Nexira. Broad incumbents are Glanbia Nutritionals, Kerry Group, Lonza Group and Innophos Holdings. Waitaki Biosciences is listed as an emerging player.

Does Pharmachem Laboratories have an API?

No public API is recorded for Pharmachem Laboratories.

What industry is Pharmachem Laboratories in?

Pharmachem Laboratories's product category is Nutraceutical Ingredients and Contract Manufacturing. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements, with a secondary code of EUAAAIAK, Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives. Its NAICS code is 3254 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireAshland completes acquisition of Pharmachem Laboratories, a leading international provider of branded nutritional and fragrance productsAshland completed its acquisition of Pharmachem Laboratories, paying $660 million in all cash. The deal is expected to be accretive to Ashland's earnings per share in the first year after closing. Pharmachem, with $300 million in annual revenues and 14 manufacturing facilities, will expand Ashland's nutraceutical and fragrance businesses.GlobeNewswireAshland to acquire Pharmachem Laboratories, a leading international provider of ingredients to global health and wellness industries and products to fragrance and flavor housesAshland Global Holdings announced a definitive agreement to acquire Pharmachem Laboratories for $660 million in all cash, expected to close before the end of the June quarter. The deal is expected to be accretive to Ashland's earnings per share in the first year after closing. Pharmachem, with annual revenues of about $300 million, will be integrated into Ashland's business.PR NewswirePhytosterols Market by Type , Application & by Region - Global Trends & Forecast to 2020A market research report estimates the global phytosterols market at $438.45 million in 2014, with projections to grow at a compound annual growth rate of 8.7% through 2020, driven by increasing health-conscious consumer demand and scientific validation of cholesterol-reduction benefits. Europe currently holds the largest market share and is expected to be the fastest-growing region, while North America remains a key market for product applications in food, beverages, pharmaceuticals, and cosmetics. Key industry players including Bunge Limited, BASF SE, Pharmachem Laboratories Inc., DuPont, and Raisio Plc dominate the competitive landscape through strategies such as mergers, acquisitions, and new product development.GlobeNewswireRaisio sold its esterification plant in the U.S.ARaisio sold its US esterification plant in Summerville, South Carolina, to Avoca Inc, a Pharmachem Laboratories subsidiary, closing on 18 April 2013. The deal centralizes plant stanol ester production to the Raisio factory and aims to improve profitability. The plant's 2012 net sales were about EUR 3.2 million excluding the ingredient.